Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1NET 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 13Rectal Neuroendocrine Tumor 2Neoplasms 2Uterine Cervical Neoplasms 1Serotonin Syndrome 1Sarcoma 1Recurrence 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Diseases 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neuroendocrine Tumors (pNET) 1Pancreatic Neoplasms 1Pancreas Adenocarcinoma (MSI-H) 1Hyperthermia 1Heart Valve Diseases 1Heart Failure 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Gastro-entero-pancreatic Neuroendocrine Tumor 1Fever 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoid Heart Disease 1Anus Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Fever × NET × Clear all
NCT04889742 2023-12-26

HETERERO

Charite University, Berlin, Germany

Phase 2 Not yet recruiting
110 enrolled
EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡